LifeCyte Innovations develops therapies targeting chronic inflammation to slow age-related diseases, including AMD and cognitive decline.
LifeCyte Innovations has raised $1.0M in total funding. The most recent round was Seed. The last funding was announced in August 2026.
LifeCyte Innovations is headquartered in Greensboro, United States.
LifeCyte Innovations develops therapies targeting chronic inflammation to slow age-related diseases, including AMD and cognitive decline.
LifeCyte Innovations is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"LifeCyte Innovations — Funding & Investors." VCBacked, August 19, 2026, https://www.vcbacked.co/company/lifecyte-innovations. Accessed September 5, 2026.
VCBacked. (2026). LifeCyte Innovations — Funding & Investors. Retrieved September 5, 2026, from https://www.vcbacked.co/company/lifecyte-innovations
{{cite web |title=LifeCyte Innovations — Funding & Investors |url=https://www.vcbacked.co/company/lifecyte-innovations |website=VCBacked |access-date=September 5, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated